Overview of the efficacy and functions of Dengzhan Xixin

Asarum is a traditional Chinese medicinal material mainly distributed in southwest my country. It has the functions of promoting blood circulation and removing blood stasis, unblocking collaterals to relieve pain, and improving microcirculation. It is often used in the treatment of cardiovascular and cerebrovascular diseases and rheumatic arthralgia. Its core functions include dilation of blood vessels, anti-platelet aggregation, antioxidant and neuroprotection, etc. Its clinical application isscutellarinas the main active ingredient. Its secondary effects include anti-inflammation, immune regulation, etc. However, please note that its pungent and warm nature and taste should be used with caution by pregnant women and those with bleeding tendencies. The pharmacological mechanism, indications, usage and precautions will be explained below.

Pharmacological mechanism and core efficacy analysis

The medicinal value of Dernigeron stems from its rich flavonoids, such asscutellarinandScutellarin. Studies have shown that these ingredients can significantly inhibit thrombosis, reduce blood viscosity, and promote cerebral blood perfusion. They are especially suitable for patients in the recovery period of ischemic stroke. Animal experiments show that scutellarin can relax vascular smooth muscle by regulating nitric oxide (NO) levels, thereby achievingdilated coronary arterieseffect. In addition, its antioxidant properties can reduce the damage of free radicals to nerve cells, providing the possibility of auxiliary treatment of Alzheimer's disease.

Indications and clinical applications

In clinical practice, Dengzhan Xixin preparations (such as Dengzhan Shengmai Capsules) are mostly used forCerebral infarction, coronary heart disease, angina pectorisandposterior circulation ischemiaand other diseases. Data show that combined with conventional treatment can improve patients' motor function scores by about 15%-20% (see Table 1). For rheumatoid arthritis, external application of its decoction can relieve joint swelling, but avoid using it with anticoagulant drugs. It should be noted that Dengzhan Xixin alone cannot replace antihypertensive or lipid-lowering drugs, but can only be used as an auxiliary method for comprehensive treatment.

Precautions and contraindications for use

The daily dosage of Dengzhan Xixin should be controlled at 10-15g. Excessive dosage may cause heart palpitations or digestive tract discomfort. Its pungent and warm properties may aggravate the symptoms of yin deficiency and excessive fire. Those with dry mouth and insomnia should be combined with yin-nourishing herbs. Absolute taboos includeacute cerebral hemorrhage, severe liver and kidney insufficiency and allergic constitution. Coagulation function needs to be monitored during medication, and the interval should be more than 2 hours when combined with aspirin. It is recommended to use it under the guidance of a physician and avoid combining it with other blood-activating drugs.

Summary and scientific understanding

As a representative medicinal material for activating blood circulation and removing blood stasis, Dengzhan Xixin has clear value in improving the prognosis of cardiovascular and cerebrovascular diseases, but its "unblocking" effect needs to be viewed rationally and cannot be deified. Modern research has confirmed that its mechanism is related to multi-target regulation, while traditional usage emphasizes syndrome differentiation and treatment. In the future, more high-quality clinical trials are needed to verify its long-term safety. Rational use of medication can give full play to its characteristics of "Asarum clears the mind without damaging the body" and provides more options for the management of chronic diseases.

Quote sources:
1. "Chinese Pharmacopoeia" 2020 Edition (National Pharmacopoeia Commission)
2. Zhang Boli et al. "Pharmacology of Traditional Chinese Medicine" People's Medical Publishing House 2017
3. Clinical data are quoted from "Chinese Journal of Integrated Traditional Chinese and Western Medicine" Issue 8, 2019